ReviewFrontiers in cell and developmental biology2025
Large language models in the management of chronic ocular diseases: a scoping review.
Review in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Advances in diagnosing and treating diabetic retinopathy.Nature reviews. Endocrinology · 2026Review
- Generative artificial intelligence in public health: a framework for governance and systemic integration.Frontiers in medicine · 2026Review
- Cross-platform evaluation of LLM-generated educational texts on cardiac myxoma: quality, readability, and actionability using network analysis and latent profile analysis.Frontiers in cardiovascular medicine · 2026Article
- Prediction of refractive error in adolescents using a multimodal large language model.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language models, a cutting-edge technology in artificial intelligence, are reshaping the new paradigm of chronic ocular diseases management. In this study, we comprehensively examined the current status and trends in the application of large language models in major blinding chronic ocular diseases such as glaucoma, cataract, and diabetic retinopathy through a systematic scoping review approach. We conducted this review based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extended to characterize the application of large language models in the field of chronic ocular diseases. The study reveals that large language models demonstrate comparable efficacy to experts in disease screening, diagnostic decision-making, personalized precision treatment recommendation, and accessibility of healthcare resources by integrating multimodal clinical data. However, the application of the technology still faces a triple challenge: (1) the limitation of model generalization ability due to the multimodal nature of clinical data; (2) the ethical controversy caused by the insufficient interpretability of algorithms; and (3) the lack of a standardized validation framework. Future directions emphasize the need for specialized model training, multimodal algorithm optimization, the establishment of a multinational multicenter clinical validation platform, and the construction of an ethical framework for dynamic regulation. Large language models are expected to evolve from an assisted decision-making tool to a core component of precision medicine for chronic ocular diseases, and ultimately to achieve an ecosystem of energy-efficient full-cycle management of chronic ocular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.